| Nancy Grace Burlak, EDD, LMFT | |
|
2255 S 88th St, Louisville, CO 80027-9716 | |
| (303) 673-9990 | |
| (303) 673-9703 |
| Full Name | Nancy Grace Burlak |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 2255 S 88th St, Louisville, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609421130 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | MFC44507 (California) | Secondary |
| 106H00000X | Marriage & Family Therapist | .0001519 (Colorado) | Primary |
| Entity Name | Poudre Valley Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760492714 PECOS PAC ID: 7618880709 Enrollment ID: O20031105000791 |
News Archive
Americans in the highest socio-economic groups have a 13 per cent greater chance of surviving a kind of stroke known as a subarachnoid hemorrhage than those in the lowest socio-economic groups, a new study has found.
Increasing the consumption of whole grain products and ensuring the successful introduction of functional cereal based foods requires an understanding of the views of consumers. The HEALTHGRAIN project of the European Union performed two consumer studies, each in four European countries, in order to study consumer expectations of healthy cereal foods, and assess the effect of claims and cues on consumer perception.
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received approval by the U.S. Food and Drug Administration (FDA) to market the therascreen EGFR test as a companion diagnostic to guide the use of Boehringer Ingelheim's new targeted therapy, GILOTRIF™ (afatinib), for treatment of metastatic NSCLC in patients whose tumors have certain EGFR gene mutations.
A new study led by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program of Bellvitge Biomedical Research Institute, ICREA researcher and Professor of Genetics at University of Barcelona discovers that colorectal tumors present epigenetic heterogeneity that relates to the clinical course of the disease.
Lung cancer treatment often pairs targeted therapies with genetic alterations driving the disease. This makes detecting these genetic alterations an essential step in diagnosis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nancy Grace Burlak, EDD, LMFT 2255 S 88th St, Louisville, CO 80027-9728 Ph: (303) 673-9990 | Nancy Grace Burlak, EDD, LMFT 2255 S 88th St, Louisville, CO 80027-9716 Ph: (303) 673-9990 |
News Archive
Americans in the highest socio-economic groups have a 13 per cent greater chance of surviving a kind of stroke known as a subarachnoid hemorrhage than those in the lowest socio-economic groups, a new study has found.
Increasing the consumption of whole grain products and ensuring the successful introduction of functional cereal based foods requires an understanding of the views of consumers. The HEALTHGRAIN project of the European Union performed two consumer studies, each in four European countries, in order to study consumer expectations of healthy cereal foods, and assess the effect of claims and cues on consumer perception.
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received approval by the U.S. Food and Drug Administration (FDA) to market the therascreen EGFR test as a companion diagnostic to guide the use of Boehringer Ingelheim's new targeted therapy, GILOTRIF™ (afatinib), for treatment of metastatic NSCLC in patients whose tumors have certain EGFR gene mutations.
A new study led by Dr. Manel Esteller, Director of the Epigenetics and Cancer Biology Program of Bellvitge Biomedical Research Institute, ICREA researcher and Professor of Genetics at University of Barcelona discovers that colorectal tumors present epigenetic heterogeneity that relates to the clinical course of the disease.
Lung cancer treatment often pairs targeted therapies with genetic alterations driving the disease. This makes detecting these genetic alterations an essential step in diagnosis.
› Verified 7 days ago
Andres Johannes Reinhard, MA, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 225 W South Boulder Rd Ste 103, Louisville, CO 80027 Phone: 720-868-9641 | |
Julie W Smith, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 801 Main St Ste 30, Louisville, CO 80027 Phone: 720-340-1155 | |
Rachelle Paige Davis, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 924 Main St, Louisville, CO 80027 Phone: 310-880-9639 | |
Mr. Larry Cappel, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 726 Mead St, Louisville, CO 80027 Phone: 303-523-6123 | |
Emily Kaptein, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1017 E South Boulder Rd Ste G, Louisville, CO 80027 Phone: 720-749-5350 | |
Dr. Jill Manning, PH.D., LMFT, CCPS Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 357 Mccaslin Blvd Ste 203, Louisville, CO 80027 Phone: 720-209-9510 Fax: 720-874-9644 |